Newcells Biotech enhances pre-clinical drug development with advanced imaging suite
Newcastle-based Newcells Biotech has unveiled a state-of-the-art imaging suite, strengthening its capabilities in pre-clinical drug development. The company, known for its in vitro models and bespoke assay services, aims to improve the prediction of in vivo human outcomes with this latest investment.


